Dr Craig Smith

A randomised controlled trial assessing the potential of palmitoylethanolamide (PEA) to act as an adjuvant to resistance training in healthy adults: a study protocol

Z Huschtscha, J Fyfe, S Feros, A Betik, C Shaw, L Main, G Abbott, S Tan, M Refalo, M Gerhardy, E Grunwald, A May, J Silver, C Smith, M White, D Hamilton

(2023), Vol. 24, Trials, C1

Co-Expression Networks Unveiled Long Non-Coding RNAs as Molecular Targets of Drugs Used to Treat Bipolar Disorder

T Truong, C Bortolasci, B Spolding, B Panizzutti, Z Liu, S Kidnapillai, M Richardson, L Gray, C Smith, O Dean, J Kim, M Berk, K Walder

(2022), Vol. 13, Frontiers in Pharmacology, C1

Cytokine-inducible SH2 domain containing protein contributes to regulation of adiposity, food intake, and glucose metabolism

W Naser, S Maymand, L Rivera, T Connor, C Liongue, C Smith, K Aston-Mourney, D McCulloch, S McGee, A Ward

(2022), Vol. 36, pp. 1-15, FASEB Journal, London, Eng., C1

Organisation of enkephalin inputs and outputs of the central nucleus of the amygdala in mice

A Viden, S Ch'ng, L Walker, A Shesham, S Hamilton, C Smith, A Lawrence

(2022), Vol. 125, Journal of Chemical Neuroanatomy, Netherlands, C1

Differential Level of RXFP3 Expression in Dopaminergic Neurons Within the Arcuate Nucleus, Dorsomedial Hypothalamus and Ventral Tegmental Area of RXFP3-Cre/tdTomato Mice

L Voglsanger, J Read, S Ch’ng, C Zhang, I Eraslan, L Gray, L Rivera, L Hamilton, R Williams, A Gundlach, C Smith

(2021), Vol. 14, Frontiers in Neuroscience, Switzerland, C1

Farmed mussels: A nutritive protein source, rich in Omega-3 fatty acids, with a low environmental footprint

E Yaghubi, S Carboni, R Snipe, C Shaw, J Fyfe, C Smith, G Kaur, S Tan, D Hamilton

(2021), Vol. 13, Nutrients, Switzerland, C1

Augmented reality in medical education: students' experiences and learning outcomes

P Dhar, T Rocks, R Samarasinghe, G Stephenson, C Smith

(2021), Vol. 26, Medical Education Online, United States, C1

Opioid analgesia and opioid-induced adverse effects: A review

A Paul, C Smith, M Rahmatullah, V Nissapatorn, P Wilairatana, M Spetea, N Gueven, N Dietis

(2021), Vol. 14, Pharmaceuticals, Switzerland, C1

Pioglitazone and deoxyribonucleoside combination treatment increases mitochondrial respiratory capacity in m.3243A>G MELAS cybrid cells

H Burgin, M Sanchez, C Smith, I Trounce, M McKenzie

(2020), Vol. 21, International Journal of Molecular Sciences, Switzerland, C1

Characterization of the relaxin family peptide receptor 3 system in the mouse bed nucleus of the stria terminalis

S Ch'ng, J Fu, R Brown, C Smith, M Hossain, S McDougall, A Lawrence

(2019), Vol. 527, pp. 2615-2633, Journal of comparative neurology, Chichester, Eng., C1

Phenotyping neurons activated in the mouse brain during restoration of salt debt

C Smith, J Cross, I Eraslan, A Attawar, S Ch'ng, P Dhar, R Samarasinghe, L Gray, A Lawrence

(2019), Vol. 101, Journal of Chemical Neuroanatomy, Netherlands, C1

The influence of opioid dependence on salt consumption and related psychological parameters in mice and humans

C Smith, J Garfield, A Attawar, D Lubman, A Lawrence

(2019), Vol. 203, pp. 19-26, Drug and Alcohol Dependence, Ireland, C1

Modulation of high fat diet-induced microbiome changes, but not behaviour, by minocycline

K Hasebe, L Rivera, C Smith, T Allnutt, T Crowley, T Nelson, O Dean, S McGee, K Walder, L Gray

(2019), Vol. 82, pp. 309-318, Brain, Behavior, and Immunity, Netherlands, C1

Salt Appetite, and the Influence of Opioids

C Smith, A Lawrence

(2018), Vol. 43, pp. 3-9, Neurochemical Research, United States, C1

Nucleus incertus corticotrophin-releasing factor 1 receptor signalling regulates alcohol seeking in rats

L Walker, H Kastman, J Koeleman, C Smith, C Perry, E Krstew, A Gundlach, A Lawrence

(2017), Vol. 22, pp. 1641-1654, Addiction Biology, United States, C1

Distribution, physiology and pharmacology of relaxin-3/RXFP3 systems in brain

S Ma, C Smith, A Blasiak, A Gundlach

(2017), Vol. 174, pp. 1034-1048, British Journal of Pharmacology, England, C1

Relaxin-3 inputs target hippocampal interneurons and deletion of hilar relaxin-3 receptors in "floxed-RXFP3" mice impairs spatial memory

M Haidar, G Guèvremont, C Zhang, R Bathgate, E Timofeeva, C Smith, A Gundlach

(2017), Vol. 27, pp. 529-546, Hippocampus, United States, C1

Relaxin-3/RXFP3 signalling in mouse hypothalamus: no effect of RXFP3 activation on corticosterone, despite reduced presynaptic excitatory input onto paraventricular CRH neurons in vitro

C Zhang, D Baimoukhametova, C Smith, J Bains, A Gundlach

(2017), Vol. 234, pp. 1725-1739, Psychopharmacology, Berlin, Germany, C1

Endogenous central amygdala mu-opioid receptor signaling promotes sodium appetite in mice

C Smith, L Walker, T Leeboonngam, M McKinley, D Denton, A Lawrence

(2016), Vol. 113, pp. 13893-13898, Proceedings of the national academy of sciences of the United States of America, Washington, D.C., C1

Sensitivity to chronic methamphetamine administration and withdrawal in mice with relaxin-3/RXFP3 deficiency

M Haidar, M Lam, B Chua, C Smith, A Gundlach

(2016), Vol. 41, pp. 481-491, Neurochemical research, New York, N.Y., C1-1

Involvement of central relaxin-3 signalling in sodium (salt) appetite

C Smith, L Walker, B Chua, M McKinley, A Gundlach, D Denton, A Lawrence

(2015), Vol. 100, pp. 1064-1072, Experimental physiology, Chichester, Eng., C1-1

Relaxin-3 receptor (Rxfp3) gene deletion reduces operant sucrose- but not alcohol-responding in mice

A Walker, C Smith, A Gundlach, A Lawrence

(2015), Vol. 14, pp. 625-634, Genes, brain and behavior, Hoboken, N.J., C1-1

Central relaxin-3 receptor (RXFP3) activation reduces elevated, but not basal, anxiety-like behaviour in C57BL/6J mice

C Zhang, B Chua, A Yang, F Shabanpoor, M Hossain, J Wade, K Rosengren, C Smith, A Gundlach

(2015), Vol. 292, pp. 125-132, Behavioural brain research, Amsterdam, The Netherlands, C1-1

Relaxin-3 receptor (RXFP3) signalling mediates stress-related alcohol preference in mice

A Walker, C Smith, B Chua, E Krstew, C Zhang, A Gundlach, A Lawrence

(2015), Vol. 10, pp. 1-71, PLoS One, San Francisco, Calif., C1-1

Relaxin-3 receptor (Rxfp3) gene knockout mice display reduced running wheel activity: implications for role of relaxin-3/RXFP3 signalling in sustained arousal

I Hosken, S Sutton, C Smith, A Gundlach

(2015), Vol. 278, pp. 167-175, Behavioural brain research, Amsterdam, The Netherlands, C1-1

Central injection of relaxin-3 receptor (RXFP3) antagonist peptides reduces motivated food seeking and consumption in C57BL/6J mice

C Smith, B Chua, C Zhang, A Walker, M Haidar, D Hawkes, F Shabanpoor, M Hossain, J Wade, K Rosengren, A Gundlach

(2014), Vol. 268, pp. 117-126, Behavioural brain research, Amsterdam, The Netherlands, C1-1

Relaxin-3/RXFP3 networks: an emerging target for the treatment of depression and other neuropsychiatric diseases?

C Smith, A Walker, I Hosken, B Chua, C Zhang, M Haidar, A Gundlach

(2014), Vol. 5, pp. 1-17, Frontiers in pharmacology, Lausanne, Switzerland, C1-1

Synthesis of fluorescent analogs of relaxin family peptides and their preliminary in vitro and in vivo characterization

L Chan, C Smith, B Chua, F Lin, R Bathgate, F Separovic, A Gundlach, M Hossain, J Wade

(2013), Vol. 1, pp. 1-9, Frontiers in chemistry, Lausanne, Switzerland, C1-1

Chemical synthesis and orexigenic activity of rat/mouse relaxin-3

M Hossain, C Smith, P Ryan, E Büchler, R Bathgate, A Gundlach, J Wade

(2013), Vol. 44, pp. 1529-1536, Amino Acids, Wien, Austria, C1-1

Potential hypothalamic targets of relaxin-3 innervation: a perspective

C Smith, B Chua, A Walker, A Gundlach

(2013), Vol. 118, pp. 47-51, Italian journal of anatomy and embryology, Firenze, Italy, C1-1

Pharmacological activation of RXFP3 is not orexigenic in C57BL/6J mice

C Smith, I Hosken, N Downer, B Chua, M Hossain, J Wade, A Gundlach

(2013), Vol. 118, pp. 52-55, Italian journal of anatomy and embryology, Firenze, Italy, C1-1

Consequences of relaxin-3 null mutation in mice on food-entrainable arousal

I Hosken, C Smith, B Chua, A Gundlach

(2013), Vol. 118, pp. 37-41, Ital J Anat Embryol, Italy, C1-1

Viral-mediated delivery of an RXFP3 agonist into brain promotes arousal in mice

C Smith, A Blasiak, D Ganella, B Chua, S Layfield, R Bathgate, A Gundlach

(2013), Vol. 118, pp. 42-46, Italian journal of anatomy and embryology, Firenze, Italy, C1-1

Relaxin-3 null mutation mice display a circadian hypoactivity phenotype

C Smith, I Hosken, S Sutton, A Lawrence, A Gundlach

(2012), Vol. 11, pp. 94-104, Genes, brain and behavior, Hoboken, N.J., C1-1

Relaxin-3 systems in the brain--the first 10 years

C Smith, P Ryan, I Hosken, S Ma, A Gundlach

(2011), Vol. 42, pp. 262-275, Journal of chemical neuroanatomy, Amsterdam, The Netherlands, C1-1

Distribution of relaxin-3 and RXFP3 within arousal, stress, affective, and cognitive circuits of mouse brain

C Smith, P-J Shen, A Banerjee, P Bonaventure, S Ma, R Bathgate, S Sutton, A Gundlach

(2010), Vol. 518, pp. 4016-4045, Journal of comparative neurology, Chichester, Eng., C1-1

Relaxin family peptides and receptors in mammalian brain

A Gundlach, S Ma, Q Sang, P-J Shen, L Piccenna, K Sedaghat, C Smith, R Bathgate, A Lawrence, G Tregear, J Wade, D Finkelstein, P Bonaventure, C Liu, T Lovenberg, S Sutton

(2009), Vol. 1160, pp. 226-235, Ann N Y Acad Sci, United States, C1-1

Eve-3: a liver enriched suppressor of Ras/MAPK signaling

J King, N Corcoran, G D'Abaco, A Straffon, C Smith, C Poon, M Buchert, S I, N Hall, P Lock, C Hovens

(2006), Vol. 44, pp. 758-767, Journal of hepatology, Amsterdam, The Netherlands, C1-1

Imatinib attenuates diabetic nephropathy in apolipoprotein E-knockout mice

M Lassila, K Jandeleit-Dahm, K Seah, C Smith, A Calkin, T Allen, M Cooper

(2005), Vol. 16, pp. 363-373, Journal of the American society of nephrology, [Washington, D.C.], C1-1

Rosiglitazone attenuates atherosclerosis in a model of insulin insufficiency independent of its metabolic effects

A Calkin, J Forbes, C Smith, M Lassila, M Cooper, K Jandeleit-Dahm, T Allen

(2005), Vol. 25, pp. 1903-1909, Arteriosclerosis, thrombosis, and vascular biology, Dallas, Tex., C1-1